from24/7 Wall St.3 weeks agoThis Former Meme Stock, Down 93%, is a High-Upside Buy Right NowModerna's stock may rebound as it transitions from COVID vaccines to a diverse mRNA product pipeline by 2026.
MiscellaneousfromBusiness Insider1 month agoIt took me almost 18 months to switch careers, and I don't know if I'd do it againRoyal Siu's job search in the pharmaceutical and biotech industries took him 18 months and 688 applications before he found success.
London startupfrom24/7 Wall St.3 months agoEli Lilly Will Be the Next $1 Trillion StockEli Lilly aims to become the first healthcare company with a $1 trillion market cap, spurred by its GLP-1 therapy leadership.Orforglipron's success in trials positions Lilly for significant market growth in obesity and diabetes management.
London startupfromBusiness Matters4 months agoUK life sciences losing 15bn a year to global rivalsThe UK's life sciences sector is losing £15 billion annually due to reduced investment and exports.